Article

Ex vivo and in vivo biological behavior of Leishmania (Viannia) shawi

São Paulo University Medical School Department of Pathology Av. Dr. Arnaldo, 455 01246-903 São Paulo SP Brazil
Parasitology Research (impact factor: 2.15). 04/2012; 105(6):1741-1747. DOI:10.1007/s00436-009-1614-7
Source: PubMed

ABSTRACT Since the first description of Leishmania (Viannia) shawi, few studies were performed with this parasite. In the present work, the in vivo and ex vivo behavior of L. (Viannia) shawi infection was studied using murine model. Peritoneal macrophages from BALB/c and C57BL/6 mice were infected with promastigotes
in the stationary phase of growth; after 24h, the infection index and nitric oxide (NO) levels in the supernatant of the
cultures were analyzed. BALB/c and C57BL/6 mice were infected into the hind footpad, and at each 2weeks, mice were sacrificed,
and the histological changes of the skin inoculation site, parasitism, and humoral immune responses were evaluated during
8weeks. Ex vivo experiments showed that macrophages of BALB/c presented higher infection index and lesser NO levels than
macrophages of C57BL/6. In vivo experiments showed that BALB/c presented higher lesion size than C57BL/6 mice; similarly,
the histopathological changes and the parasitism in skin were more exacerbate in BALB/c mice. In draining lymph nodes, the
main change was increase of germinative centers, and parasites were detected from 6weeks pi onwards in both mice strain.
IgG was detected in BALB/c mice from 4weeks, while in C57BL/6, from 6weeks pi onwards. Taken together, these results indicate
that BALB/c showed a classical behavior of susceptibility when compared to C57BL/6 mice.

0 0
 · 
1 Bookmark
 · 
81 Views
  • Source
    Article: Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation.
    [show abstract] [hide abstract]
    ABSTRACT: Leishmania (Viannia) shawi parasite was first characterized in 1989. Recently the protective effects of soluble leishmanial antigen (SLA) from L. (V.) shawi promastigotes were demonstrated using BALB/c mice, the susceptibility model for this parasite. In order to identify protective fractions, SLA was fractionated by reverse phase HPLC and five antigenic fractions were obtained. F1 fraction was purified from L. (V.) shawi parasite extract by reverse phase HPLC. BALB/c mice were immunized once a week for two consecutive weeks by subcutaneous routes in the rump, using 25 μg of F1. After 1 and 16 weeks of last immunization, groups were challenged in the footpad with L. (V.) shawi promastigotes. After 2 months, those same mice were sacrificed and parasite burden, cellular and humoral immune responses were evaluated. The F1 fraction induced a high degree of protection associated with an increase in IFN-γ, a decrease in IL-4, increased cell proliferation and activation of CD8+T lymphocytes. Long-term protection was acquired in F1-immunized mice, associated with increased CD4+ central memory T lymphocytes and activation of both CD4+ and CD8+ T cells. In addition, F1-immunized groups showed an increase in IgG2a levels. The inductor capability of antigens to generate memory lymphocytes that can proliferate and secrete beneficial cytokines upon infection could be an important factor in the development of vaccine candidates against American Tegumentary Leishmaniasis.
    Parasites & Vectors 03/2012; 5:64. · 2.94 Impact Factor

Full-text (3 Sources)

View
21 Downloads
Available from
8 Dec 2012

Keywords

BALB/c mice
 
classical behavior
 
draining lymph nodes
 
ex vivo behavior
 
Ex vivo experiments
 
first description
 
germinative centers
 
higher infection index
 
higher lesion size
 
histological changes
 
histopathological changes
 
humoral immune responses
 
infection index
 
murine model
 
nitric oxide
 
parasites
 
Peritoneal macrophages
 
skin inoculation site
 
stationary phase
 
vivo experiments